30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

NuVasive Gains FDA Clearance for COHERE in XLIF -

NuVasive received FDA 510(k) clearance for use of the COHERE® Porous PEEK™ implant in XLIF® eXtreme Lateral Interbody Fusion. U.S. commercial launch will occur in 2Q19. The clearance supports use of the interbody device with autograft and allograft to treat degenerative disc disease, degenerative spondylolisthesis and degenerative scoliosis. (NuVasive, Inc., 11/8/18)